Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients. 2017

Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
Surgical Intensive Care Unit, Department of Anesthesiology and Intensive Care, Hospital Clínico Universitario de Valencia, Avenida Blasco Ibáñez, 17, 46010, Valencia, Spain. gerardo.aguilar@uv.es.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077336 Caspofungin A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES. Cancidas,Caspofungin Acetate,Caspofungin MSD,L 743,872,L 743872,L-743,872,L-743872,MK 0991,MK-0991,L743,872,L743872,MK0991
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical
D017583 Hemodiafiltration The combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport (hemofiltration) may be better for removal of larger molecular weight substances and diffusive transport (hemodialysis) for smaller molecular weight solutes. Acetate-Free Biofiltration,Biofiltration, Acetate-Free,Acetate Free Biofiltration,Acetate-Free Biofiltrations,Biofiltration, Acetate Free,Biofiltrations, Acetate-Free
D054714 Echinocandins Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS. Aculeacin,Echinocandin,Pneumocandin,Aculeacins,Mulundocandins,Pneumocandins
D055666 Lipopeptides Compounds consisting of a short peptide chain conjugated with an acyl chain. Lipopeptide,Anionic Lipopeptide,Anionic Lipopeptides,Cationic Lipopeptide,Cationic Lipopeptides,Lipopeptide, Anionic,Lipopeptide, Cationic,Lipopeptides, Anionic,Lipopeptides, Cationic
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
January 2014, Antimicrobial agents and chemotherapy,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
February 2002, Pharmacotherapy,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
May 2000, Ugeskrift for laeger,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
April 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
December 2003, Journal of clinical pharmacology,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
August 2004, The American journal of clinical nutrition,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
December 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
September 2001, Acta anaesthesiologica Scandinavica,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
January 2014, Antimicrobial agents and chemotherapy,
Gerardo Aguilar, and Rafael Ferriols, and Angels Lozano, and Carlos Ezquer, and José A Carbonell, and Ana Jurado, and Juan Carrizo, and Ferran Serralta, and Jaume Puig, and David Navarro, and Manuel Alos, and F Javier Belda
October 2008, The Japanese journal of antibiotics,
Copied contents to your clipboard!